Cited by 122Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsClinical practice guidelines implementation

The DOI matches its Crossref record; 752 of the 752 references it cites were found in a registry or an index.

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Writing Committee Members, Blumenthal, Roger S., Morris, Pamela B., Gaudino, Mario, Johnson, Heather M., Anderson, Timothy S., Bittner, Vera A., Blankstein, Ron, Brewer, LaPrincess C., Cho, Leslie, de Ferranti, Sarah D., Gianos, Eugenia, Gluckman, Ty J., Gradney, Kristen F., Isiadinso, Ijeoma, Lloyd-Jones, Donald M., Marrs, Joel C., Martin, Seth S., McLain, Kellie H., Mehta, Laxmi S., Mora, Samia, Mulugeta, Wudeneh M., Natarajan, Pradeep, Navar, Ann Marie, Orringer, Carl E., Polonsky, Tamar S., Reynolds, Harmony R., Saseen, Joseph J., Shapiro, Michael D., Soffer, Daniel E., Tynes, Sheila A., Villavaso, Chloé D., Virani, Salim S., Wilkins, John T., Rohatgi, Anand, Kim, Samuel M., Alexander, Karen P., Anderson, Cheryl, Benziger, Catherine P., Dixon, Dave L., Duprez, Daniel, Ferdinand, Keith C., Goldberg, Anne Carol, Joshi, Parag, Knowles, Joshua W., Lavie Jr, Carl (Chip) J., Linderbaum, Jane A., McEvoy, John William, Mehta, Anurag, Merz, C. Noel Bairey, Nambi, Vijay, Orkaby, Ariela R., Peña,, Jessica M., Rosenson, Robert, Ruisinger, Janelle, Sandner, Sigrid E., Schott, Stacey L., Sperling, Laurence (Larry), Stone, Neil J., Toth, Peter, Ware, Adam L., Whelton, Seamus Paul, Young, James·2026·Circulation

DOI 10.1161/cir.0000000000001423

Open this paper in CoChat — free account

Abstract

AIM: The “2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia” retires and replaces the “2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol.” METHODS: A comprehensive literature search was conducted from October 2024 to December 2024 to identify clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. STRUCTURE: The focus of this clinical practice guideline is to address the evaluation, management, and monitoring of individuals with dyslipidemias, including high blood cholesterol, hypertriglyceridemia, and elevated lipoprotein(a).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000001423

Cites

752 of 752 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Items 401–600 of 752

The Effect of Exercise Training on Blood Lipids: A Systematic Review and Meta-analysis
Smart, N. A., Downes, D., van der Touw, T., Hada, S., Dieberg, G., Pearson, M. J., Wolden, M., King, N., & Goodman, S. P. J. (2025) · Sports Medicine · doi:10.1007/s40279-024-02115-z · Cited by 126
Weight loss and serum lipids in overweight and obese adults: A systematic review and meta-analysis
Hasan, B., Nayfeh, T., Alzuabi, M., Wang, Z., Kuchkuntla, A. R., Prokop, L. J., Newman, C. B., Murad, M. H., & Rajjo, T. I. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa673 · Cited by 126
Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial
Mora, S., Caulfield, M. P., Wohlgemuth, J., Chen, Z., Superko, H. R., Rowland, C. M., Glynn, R. J., Ridker, P. M., & Krauss, R. M. (2015) · Circulation · doi:10.1161/circulationaha.115.016857 · Cited by 126
Self-citation
Comparison of aerobic exercise, diet or both on lipids and lipoproteins in adults: A meta-analysis of randomized controlled trials
Kelley, G. A., Kelley, K. S., Roberts, S., & Haskell, W. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2011.11.011 · Cited by 125
When Does a Calcium Score Equate to Secondary Prevention?
Budoff, M. J., Kinninger, A., Gransar, H., Achenbach, S. S., Al-Mallah, M. H., Bax, J. J., Berman, D. S., Cademartiri, F., Callister, T. Q., Chang, H., et al. (2023) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2023.03.008 · Cited by 125
Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span
Williams, L., Rhodes, K. S., Karmally, W., Welstead, L. A., Alexander, L., & Sutton, L. (2018) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2018.04.010 · Cited by 125
Trends in Levels of Lipids and Apolipoprotein B in US Youths Aged 6 to 19 Years, 1999-2016
Perak, A. M., Ning, H., Kit, B. K., de Ferranti, S. D., Horn, L. V., Wilkins, J. T., & Lloyd‐Jones, D. M. (2019) · JAMA · doi:10.1001/jama.2019.4984 · Cited by 124
Self-citation
Association of Adverse Pregnancy Outcomes With Risk of Atherosclerotic Cardiovascular Disease in Postmenopausal Women
Søndergaard, M. M., Hlatky, M. A., Stefanick, M. L., Vittinghoff, E., Nah, G., Allison, M., Gemmill, A., Horn, L. V., Park, K. E., Salmoirago‐Blotcher, E., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.4097 · Cited by 124
Secondary Causes of Dyslipidemia
Vodnala, D., Rubenfire, M., & Brook, R. D. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.04.062 · Cited by 123
Racial Differences in the Cholesterol-Lowering Effect of Statin
Naito, R., Miyauchi, K., & Daida, H. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv16004 · Cited by 123
Analysis of Efficacy and Safety in Patients Aged 65–75 Years at Randomization
Neil, H. A. W., DeMicco, D. A., Luo, D., Betteridge, D. J., Colhoun, H. M., Durrington, P. N., Livingstone, S. J., Fuller, J., Hitman, G. A., & on behalf of the CARDS Study Investigators (2006) · Diabetes Care · doi:10.2337/dc06-0872 · Cited by 122
Fasting versus nonfasting and low-density lipoprotein cholesterol accuracy
Sathiyakumar, V., Park, J., Golozar, A., Lazo, M., Quispe, R., Guallar, E., Blumenthal, R. S., Jones, S. R., & Martin, S. S. (2018) · Circulation · doi:10.1161/circulationaha.117.030677 · Cited by 122
Self-citation
Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study
Yu, H., Chen, P., Yang, Y., Wang, L., Lee, J., Lin, Y., & Chiang, B. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.08.030 · Cited by 120
Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study
Perrot, N., Verbeek, R., Sandhu, M. S., Boekholdt, S. M., Hovingh, G. K., Wareham, N. J., Khaw, K., & Arsenault, B. J. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.11.010 · Cited by 120
Interactions Between Enhanced Polygenic Risk Scores and Lifestyle for Cardiovascular Disease, Diabetes, and Lipid Levels
Ye, Y., Chen, X. D., Han, J. J., Jiang, W., Natarajan, P., & Zhao, H. (2021) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.120.003128 · Cited by 119
Self-citation
Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort
Fuchs, A., Kühl, J. T., Sigvardsen, P. E., Afzal, S., Knudsen, A. D., Møller, M. B., de Knegt, M. C., Sørgaard, M. H., Nordestgaard, B. G., Køber, L., et al. (2023) · Annals of Internal Medicine · doi:10.7326/m22-3027 · Cited by 119
A Mediterranean Diet and Low-Fat Vegan Diet to Improve Body Weight and Cardiometabolic Risk Factors: A Randomized, Cross-over Trial
Barnard, N. D., Alwarith, J., Rembert, E., Brandon, L., Nguyen, M., Goergen, A., Horne, T., do Nascimento, G. F., Lakkadi, K., Tura, A., et al. (2022) · Journal of the American Nutrition Association · doi:10.1080/07315724.2020.1869625 · Cited by 119
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Hagström, E., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Danchin, N., Diaz, R., Goodman, S. G., Harrington, R. A., Jukema, J. W., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057807 · Cited by 118
Self-citation
Adverse pregnancy outcomes and long term risk of ischemic heart disease in mothers: national cohort and co-sibling study
Crump, C., Sundquist, J., McLaughlin, M. A., Dolan, S. M., Govindarajulu, U. S., Sieh, W., & Sundquist, K. (2023) · BMJ · doi:10.1136/bmj-2022-072112 · Cited by 115
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association
Soffer, D. E., Marston, N. A., Maki, K. C., Jacobson, T. A., Bittner, V. A., Peña, J. M., Thanassoulis, G., Martin, S. S., Kirkpatrick, C. F., Virani, S. S., et al. (2024) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2024.08.013 · Cited by 115
Self-citation
Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults
Yano, Y., O’Donnell, C. J., Kuller, L. H., Kavousi, M., Erbel, R., Ning, H., D’Agostino, R. B., Newman, A. B., Nasir, K., Albert Hofman, D., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.2498 · Cited by 113
Self-citation
Association of Coronary Artery Calcium and Coronary Heart Disease Events in Young and Elderly Participants in the Multi-Ethnic Study of Atherosclerosis
Tota-Maharaj, R., Blaha, M. J., Blankstein, R., Silverman, M. G., Eng, J., Shaw, L. J., Blumenthal, R. S., Budoff, M. J., & Nasir, K. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.05.017 · Cited by 112
Self-citation
Patient-Centered Adult Cardiovascular Care: A Scientific Statement From the American Heart Association
Goldfarb, M., Saylor, M. A., Bozkurt, B., Code, J., Palo, K. E. D., Durante, Á., Flanary, K., Creber, R. M., Ogunniyi, M. O., Rodríguez, F., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001233 · Cited by 112
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association
Warden, B. A., Guyton, J. R., Kovacs, A. C., Durham, J. A., Jones, L. K., Dixon, D. L., Jacobson, T. A., & Duell, P. B. (2023) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2022.09.001 · Cited by 111
Self-citation
Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria—a prospective population-based cohort study
Ollila, M., Arffman, R. K., Korhonen, E., Morin-Papunen, L. C., Franks, S., Junttila, J. M., & Piltonen, T. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad077 · Cited by 110
Blood Lipids in Children: Age-Related Patterns and Association with Body-Fat Indices
Dai, S., Fulton, J. E., Harrist, R. B., Grunbaum, J. A., Steffen, L. M., & Labarthe, D. R. (2009) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2009.04.012 · Cited by 110
Relationship of lipoprotein(a) molar concentrations and mass according to lipoprotein(a) thresholds and apolipoprotein(a) isoform size
Tsimikas, S., Fazio, S., Viney, N. J., Xia, S., Witztum, J. L., & Marcovina, S. M. (2018) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2018.07.003 · Cited by 109
Immune activation and cardiovascular disease in chronic HIV infection
Longenecker, C. T., Sullivan, C., & Baker, J. V. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000227 · Cited by 108
Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction
Singh, A., Gupta, A., Collins, B., Qamar, A., Monda, K. L., Biery, D. W., López, J. A. G., de Ferranti, S. D., Plutzky, J., Cannon, C. P., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.059 · Cited by 108
Self-citation
Review of Side-Effect Profile of Combination Ezetimibe and Statin Therapy in Randomized Clinical Trials
Kashani, A., Sallam, T., Bheemreddy, S., Mann, D. L., Wang, Y., & Foody, J. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.01.041 · Cited by 107
Repeat Measures of Lipoprotein(a) Molar Concentration and Cardiovascular Risk
Trinder, M., Paruchuri, K., Haidermota, S., Bernardo, R. C., Zekavat, S. M., Gilliland, T., Januzzi, J. L., & Natarajan, P. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.11.055 · Cited by 106
Self-citation
Therapeutic Inertia in Cardiovascular Disease Prevention
Dixon, D. L., Sharma, G. V., Sandesara, P. B., Yang, E., Braun, L. T., Mensah, G. A., Sperling, L. S., DEEDWANIA, P. C., & Virani, S. S. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.08.014 · Cited by 105
Self-citation
Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3‐hydroxy‐3‐methylglutaryl‐coenzyme a reductase
Minsker, D. H., MacDonald, J. S., Robertson, R. T., & Bokelman, D. L. (1983) · Teratology · doi:10.1002/tera.1420280316 · Cited by 104
Integrative polygenic risk score improves the prediction accuracy of complex traits and diseases
Truong, B. M. T., Hull, L. E., Ruan, Y., Huang, Q., Hornsby, W., Martin, H. C., van Heel, D. A., Wang, Y., Martin, A. R., Lee, S., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100523 · Cited by 104
Self-citation
Performance of Four Homogeneous Direct Methods for LDL-Cholesterol
Miller, W. G., Waymack, P. P., Anderson, F. P., Ethridge, S. F., & Jayne, E. C. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.489 · Cited by 104
Discordance between circulating atherogenic cholesterol mass and lipoprotein particle concentration in relation to future coronary events in women
Lawler, P. R., Akinkuolie, A. O., Ridker, P. M., Sniderman, A. D., Buring, J. E., Glynn, R. J., Chasman, D. I., & Mora, S. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.264515 · Cited by 104
Self-citation
Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia
Wiegman, A., Greber‐Platzer, S., Ali, S., Reijman, M. D., Brinton, E. A., Charng, M., Srinivasan, S., Baker-Smith, C. M., Baum, S. J., Brothers, J. A., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.065529 · Cited by 103
Statin Therapy Alters the Relationship Between Apolipoprotein B and Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol Targets in High-Risk Patients
Ballantyne, C. M., Raichlen, J. S., & Cain, V. A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.052 · Cited by 102
Shift work, and particularly permanent night shifts, promote dyslipidaemia: A systematic review and meta-analysis
Dutheil, F., Baker, J. S., Mermillod, M., Cesare, M. D., Vidal, A., Moustafa, F., Pereira, B., & Navel, V. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.08.015 · Cited by 102
Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator
Khera, A., Budoff, M. J., O’Donnell, C. J., Ayers, C. R., Locke, J. P., de Lemos, J. A., Massaro, J. M., McClelland, R. L., Taylor, A. J., & Levine, B. D. (2018) · Circulation · doi:10.1161/circulationaha.118.033505 · Cited by 101
Statin Discontinuation and Cardiovascular Events Among Older People in Denmark
Thompson, W., Morin, L., Jarbøl, D. E., Andersen, J. H., Ernst, M. T., Nielsen, J. B., Haastrup, P., Schmidt, M., & Pottegård, A. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.36802 · Cited by 101
Primary Prevention of Major Cardiovascular and Cerebrovascular Events with Statins in Diabetic Patients
de Vries, F. M., Denig, P., Pouwels, K. B., Postma, M. J., & Hak, E. (2012) · Drugs · doi:10.2165/11638240-000000000-00000 · Cited by 99
The effects of exercise on the lipoprotein subclass profile: A meta-analysis of 10 interventions
Sarzynski, M. A., Burton, J. H., Rankinen, T., Blair, S. N., Church, T. S., Després, J., Hagberg, J. M., Landers‐Ramos, R. Q., Leon, A. S., Mikus, C. R., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.018 · Cited by 99
Fiber supplements and clinically proven health benefits
Lambeau, K. V., & McRorie, J. W. (2017) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12447 · Cited by 99
Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients
Lloyd‐Jones, D. M., Huffman, M. D., Karmali, K. N., Sanghavi, D. M., Wright, J. S., Pelser, C. B., Gulati, M., Masoudi, F. A., & Goff, D. C. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.018 · Cited by 99
Self-citation
Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial
Ray, K. K., Nicholls, S. J., Li, N., Louie, M. J., Brennan, D., Lincoff, A. M., & Nissen, S. E. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00316-9 · Cited by 99
Cardiovascular Disease and Thrombosis in HIV Infection
Perkins, M. V., Joseph, S., Dittmer, D. P., & Mackman, N. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318232 · Cited by 98
Liver safety of statins in prediabetes or T2DM and nonalcoholic steatohepatitis: post hoc analysis of a randomized trial
Bril, F., Portillo Sanchez, P., Lomonaco, R., Orsak, B., Hecht, J., Tio, F., & Cusi, K. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00867 · Cited by 97
Impact of Intensive LDL Cholesterol Lowering on Coronary Artery Atherosclerosis Progression
Shin, S., Park, H., Chang, H., Arsanjani, R., Min, J. K., Kim, Y.-J., Lee, B. K., Choi, J.-H., Hong, G., & Chung, N. (2016) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2016.04.013 · Cited by 96
Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood
Raitakari, O. T., Kartiosuo, N., Pahkala, K., Hutri‐Kähönen, N., Bazzano, L., Chen, W., Urbina, E. M., Jacobs, D. R., Sinaiko, A. R., Steinberger, J., et al. (2022) · Circulation · doi:10.1161/circulationaha.122.060667 · Cited by 96
Effects of Statins on Triglyceride Metabolism
Ginsberg, H. N. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00035-6 · Cited by 96
History of Gestational Diabetes Mellitus in Relation to Cardiovascular Disease and Cardiovascular Risk Factors in US Women
Shostrom, D. C. V., Sun, Y., Oleson, J. J., Snetselaar, L. G., & Bao, W. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00144 · Cited by 96
Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical Trial
Raal, F., Durst, R., Bi, R., Talloczy, Z., Maheux, P., Lesogor, A., Kastelein, J. J. P., & on behalf of the ORION-5 Study Investigators (2024) · Circulation · doi:10.1161/circulationaha.122.063460 · Cited by 96
Distribution of Coronary Artery Calcium by Age, Sex, and Race Among Patients 30-45 Years Old
Javaid, A., Dardari, Z., Mitchell, J. D., Whelton, S. P., Dzaye, O. D. A., Lima, J. A. C., Lloyd‐Jones, D. M., Budoff, M. J., Nasir, K., Berman, D. S., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.02.051 · Cited by 94
Self-citation
Coronary Atherosclerosis in an Asymptomatic U.S. Population
Nasir, K., Cainzos‐Achirica, M., Elizondo, J. V., Ali, S. S., Havistin, R., Lakshman, S., Blaha, M. J., Blankstein, R., Shapiro, M. D., Arias, L., et al. (2022) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2022.03.010 · Cited by 94
Self-citation
The Effect of Dietary Interventions on Hypertriglyceridemia: From Public Health to Molecular Nutrition Evidence
Luna-Castillo, K. P., Olivares-Ochoa, X. C., Hernández-Ruíz, R. G., Llamas-Covarrubias, I. M., Rodríguez-Reyes, S. C., Betancourt‐Núñez, A., Vizmanos-Lamotte, B., Martínez‐López, E., Muñóz-Valle, J. F., Márquez‐Sandoval, F., et al. (2022) · Nutrients · doi:10.3390/nu14051104 · Cited by 94
A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia
Costantine, M. M., West, H. A., Wisner, K. L., Caritis, S. N., Clark, S. M., Venkataramanan, R., Stika, C. S., Rytting, E., Wang, X., Ahmed, M. S., et al. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.05.018 · Cited by 93
Familial Chylomicronemia Syndrome: A Clinical Guide for Endocrinologists
Falko, J. M. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0157 · Cited by 93
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV
Lu, M. T., Ribaudo, H. J., Foldyna, B., Zanni, M. V., Mayrhofer, T., Karády, J., Taron, J., Fitch, K. V., McCallum, S., Burdo, T. H., et al. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2023.5661 · Cited by 93
Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular Disease
Fonarow, G. C., van Hout, B., Villa, G., Arellano, J., & Lindgren, P. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1647 · Cited by 91
Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention
Elder, P., Sharma, G. V., Gulati, M., & Michos, E. D. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100028 · Cited by 91
Pragmatic evaluation of events and benefits of lipid lowering in older adults ( PREVENTABLE ): Trial design and rationale
Joseph, J., Pajewski, N. M., Dolor, R. J., Sellers, M. A., Perdue, L., Peeples, S. R., Henrie, A. M., Woolard, N., Jones, W. S., Benziger, C. P., et al. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18312 · Cited by 91
Self-citation
Prospective deep learning–based quantitative assessment of coronary plaque by computed tomography angiography compared with intravascular ultrasound: the REVEALPLAQUE study
Narula, J., Stuckey, T., Nakazawa, G., Ahmadi, A. A., Matsumura, M., Petersen, K., Mirza, S., Ng, N., Mullen, S., Schaap, M., et al. (2024) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeae115 · Cited by 91
Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: A nationwide observational study from the Swedish National Diabetes Register
Svensson, M. K. E., Cederholm, J., Eliasson, B., Zethelius, B., & Guðbjörnsdóttir, S. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113500798 · Cited by 90
Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia
Paquette, M., Bernard, S., Cariou, B., Hegele, R. A., Genest, J. J., Trinder, M., Brunham, L. R., Béliard, S., & Baass, A. W. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316106 · Cited by 90
The Montreal-FH-SCORE: A new score to predict cardiovascular events in familial hypercholesterolemia
Paquette, M., Dufour, R., & Baass, A. W. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.10.004 · Cited by 89
Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use
Mora, S. (2009) · Circulation · doi:10.1161/circulationaha.108.819359 · Cited by 89
Self-citation
Absence of Coronary Artery Calcium Identifies Asymptomatic Diabetic Individuals at Low Near-Term But Not Long-Term Risk of Mortality
Valenti, V., Hartaigh, B. Ó., Cho, I., Schulman‐Marcus, J., Gransar, H., Heo, R., Truong, Q. A., Shaw, L. J., Knapper, J. T., Kelkar, A. A., et al. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.003528 · Cited by 88
Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial
Nurmohamed, N. S., Min, J. K., Anthopolos, R., Reynolds, H. R., Earls, J. P., Crabtree, T. R., Mancini, G. B. J., Leipsic, J. A., Budoff, M. J., Hague, C. J., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae471 · Cited by 88
Self-citation
Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaboration
Cobbaert, C. M., Althaus, H., Brkovic, I. B., Ceglarek, U., Coassin, S., Delatour, V., Deprez, L., Dikaios, I., Dittrich, J., Hoofnagle, A. N., et al. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa239 · Cited by 88
Mortality Rates in Smokers and Nonsmokers in the Presence or Absence of Coronary Artery Calcification
McEvoy, J. W., Blaha, M. J., Rivera, J. J., Budoff, M. J., Khan, A. N., Shaw, L. J., Berman, D. S., Raggi, P., Min, J. K., Rumberger, J. A., et al. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.02.017 · Cited by 87
Self-citation
Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein B
Sniderman, A. D., Tremblay, A., Bergeron, J., Gagné, C., & Couture, P. (2007) · Journal of clinical lipidology · doi:10.1016/j.jacl.2007.07.006 · Cited by 87
Developmental toxicity of the HMG‐CoA reductase inhibitor, atorvastatin, in rats and rabbits
Dostal, L. A., Schardein, J. L., & Anderson, J. A. (1994) · Teratology · doi:10.1002/tera.1420500604 · Cited by 87
Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers
Laffin, L. J., Bruemmer, D., García, M. G., Brennan, D. M., McErlean, E. S., Jacoby, D. S., Michos, E. D., Ridker, P. M., Wang, T. Y., Watson, K. E., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.10.013 · Cited by 87
Polygenic risk score adds to a clinical risk score in the prediction of cardiovascular disease in a clinical setting
Samani, N. J., Beeston, E., Greengrass, C., Riveros-Mckay, F., Dębiec, R., Lawday, D., Wang, Q., Budgeon, C. A., Braund, P. S., Bramley, R., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae342 · Cited by 86
All-cause and cause-specific mortality in individuals with zero and minimal coronary artery calcium: A long-term, competing risk analysis in the Coronary Artery Calcium Consortium
Blaha, M. J., Cainzos‐Achirica, M., Dardari, Z., Blankstein, R., Shaw, L. J., Rozanski, A., Rumberger, J. A., Dzaye, O. D. A., Michos, E. D., Berman, D. S., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.11.008 · Cited by 86
Self-citation
Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis
Bello, N., Meyers, K. J., Workman, J., Hartley, L., & McMahon, M. A. (2022) · Lupus · doi:10.1177/09612033221147471 · Cited by 86
Lipoprotein Apheresis: Utility, Outcomes, and Implementation in Clinical Practice: A Scientific Statement From the American Heart Association
Gianos, E., Duell, P. B., Toth, P. P., Moriarty, P. M., Thompson, G. R., Brinton, E. A., Hudgins, L. C., Nametka, M., Byrne, K., Raghuveer, G., et al. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atv.0000000000000177 · Cited by 85
Self-citation
Clinical and Cost Benefits of Medical Nutrition Therapy by Registered Dietitian Nutritionists for Management of Dyslipidemia: A Systematic Review and Meta-Analysis
Sikand, G., Cole, R. E., Handu, D., deWaal, D., Christaldi, J., Johnson, E. Q., Arpino, L. M., & Ekvall, S. M. (2018) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2018.06.016 · Cited by 84
Severe gestational hypertriglyceridemia: A practical approach for clinicians
Wong, B., Ooi, T. C., & Keely, E. (2015) · Obstetric Medicine · doi:10.1177/1753495x15594082 · Cited by 83
Residential greenness and blood lipids in urban-dwelling adults: The 33 Communities Chinese Health Study
Yang, B., Markevych, I., Heinrich, J., Bloom, M. S., Qian, Z. M., Geiger, S. D., Vaughn, M. G., Liu, S., Guo, Y., Dharmage, S. C., et al. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.03.128 · Cited by 83
Influence of Subclinical Atherosclerosis Burden and Progression on Mortality
Fuster, V., García‐Álvarez, A., Devesa, A., Mass, V., Owen, R., Quesada, A. J., Fuster, J. J., García‐Lunar, I., Pocock, S., Sánchez‐Gonzalez, J., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.045 · Cited by 83
Exercise Training, Lipid Regulation, and Insulin Action: A Tangled Web of Cause and Effect
Kraus, W. E., & Slentz, C. A. (2009) · Obesity · doi:10.1038/oby.2009.384 · Cited by 82
Efficacy and Safety of Ezetimibe Monotherapy in Children with Heterozygous Familial or Nonfamilial Hypercholesterolemia
Kusters, D. M., Caceres, M., Mauricio Coll, B., Cuffie, C. A., Gagné, C., Jacobson, M. S., Kwiterovich, P. O., Lee, R., Lowe, R. S., Massaad, R., et al. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.02.043 · Cited by 82
US Trends in Cholesterol Screening, Lipid Levels, and Lipid‐Lowering Medication Use in US Adults, 1999 to 2018
Gao, Y., Shah, L. M., Ding, J., & Martin, S. S. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028205 · Cited by 82
Self-citation
Effects of low glycaemic index/low glycaemic load vs. high glycaemic index/ high glycaemic load diets on overweight/obesity and associated risk factors in children and adolescents: a systematic review and meta-analysis
Schwingshackl, L., Hobl, L. P., & HOFFMANN, G. E. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0077-1 · Cited by 81
Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry
Duell, P. B., Gidding, S. S., Andersen, R. L., Knickelbine, T., Anderson, L., Gianos, E., Shrader, P. J., Kindt, I., O'Brien, E. C., McCann, D., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.007 · Cited by 81
Self-citation
Prescribing exercise in primary care
Khan, K., Weiler, R., & Blair, S. N. (2011) · BMJ · doi:10.1136/bmj.d4141 · Cited by 80
The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes
Budoff, M. J., Backlund, J. C., Bluemke, D. A., Polak, J. F., Bebu, I., Schade, D. S., Strowig, S. M., Raskin, P., & Lachin, J. M. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2019.01.014 · Cited by 80
Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)
Zoungas, S., Curtis, A. J., Spark, S., Wolfe, R. S., McNeil, J. J., Beilin, L. J., Chong, T. T. ‐., CLOUD, G. C., Hopper, I., Kost, A., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-069915 · Cited by 80
Risk of myocardial infarction in men and women with type 2 diabetes in the UK: a cohort study using the General Practice Research Database
Mulnier, H. E., Seaman, H. E., Raleigh, V. S., Soedamah‐Muthu, S. S., Colhoun, H. M., Lawrenson, R. A., & de Vries, C. S. (2008) · Diabetologia · doi:10.1007/s00125-008-1076-y · Cited by 79
New Case Detection by Cascade Testing in Familial Hypercholesterolemia
Lee, C., Rivera-Valerio, M., Bangash, H., Prokop, L., & Kullo, I. J. (2019) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.119.002723 · Cited by 79
Effects of Exercise on the Body Composition and Lipid Profile of Individuals with Obesity: A Systematic Review and Meta-Analysis
Kim, K.-B., Kim, K., Kim, C., Kang, S.-J., Kim, H. J., Yoon, S., & Shin, Y.-A. (2019) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes.2019.28.4.278 · Cited by 79
Colesevelam Hydrochloride: Efficacy and Safety in Pediatric Subjects with Heterozygous Familial Hypercholesterolemia
Stein, E. A., Marais, A. D., Szamosi, T., Raal, F. J., Schurr, D., Urbina, E. M., Hopkins, P. N., Karki, S., Xu, J., Misir, S., et al. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.08.037 · Cited by 78
Advanced Lipoprotein Testing and Subfractionation Are Clinically Useful
Superko, H. R. (2009) · Circulation · doi:10.1161/circulationaha.108.809582 · Cited by 78
Fasting or Nonfasting Lipid Measurements
Driver, S. L., Martin, S. S., Gluckman, T. J., Clary, J. M., Blumenthal, R. S., & Stone, N. J. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.047 · Cited by 78
Self-citation
Effects of 20-year infancy-onset dietary counselling on cardiometabolic risk factors in the Special Turku Coronary Risk Factor Intervention Project (STRIP): 6-year post-intervention follow-up
Pahkala, K., Laitinen, T. T., Niinikoski, H., Kartiosuo, N., Rovio, S., Lagström, H., Loo, B.-M., Salo, P., Jokinen, E. V., Magnussen, C. G., et al. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30059-6 · Cited by 78
Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk study
Kraaijenhof, J. M., Nurmohamed, N. S., Nordestgaard, A. T., Reeskamp, L. F., Stroes, E. S. G., Hovingh, G. K., Boekholdt, S. M., & Ridker, P. M. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf209 · Cited by 78
Supporting Physical Activity in Patients and Populations During Life Events and Transitions: A Scientific Statement From the American Heart Association
Lane‐Cordova, A. D., Jerome, G. J., Paluch, A. E., Bustamante, E. E., LaMonte, M. J., Pate, R. R., Weaver, R. G., Webber‐Ritchey, K. J., & Gibbs, B. B. (2021) · Circulation · doi:10.1161/cir.0000000000001035 · Cited by 78
Creatine kinase in the U.S. population
George, M., McGill, N., & Baker, J. F. (2016) · Medicine · doi:10.1097/md.0000000000004344 · Cited by 77
Early Menopause and Cardiovascular Disease Risk in Women With or Without Type 2 Diabetes: A Pooled Analysis of 9,374 Postmenopausal Women
Yoshida, Y., Chen, Z., Baudier, R. L., Krousel-Wood, M. A., Anderson, A. H., Fonseca, V. A., & Mauvais‐Jarvis, F. (2021) · Diabetes Care · doi:10.2337/dc21-1107 · Cited by 77
Perinatal Outcomes After Statin Exposure During Pregnancy
Chang, J., Chen, Y., Chen, I., Lin, W., Chen, Y., & Lin, C. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.41321 · Cited by 77
South Asian ethnicity as a risk factor for coronary heart disease
Pursnani, S. K., & Merchant, M. A. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.10.007 · Cited by 76
Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events
Wu, F., Juonala, M., Jacobs, D. R., Daniels, S. R., Kähönen, M. A. P., Woo, J. G., Sinaiko, A. R., Viikari, J. S. A., Bazzano, L., Burns, T. L., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.064296 · Cited by 76
Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia
Trinder, M., DeCastro, M. L., Azizi, H., Cermakova, L., Jackson, L. M., Frohlich, J., Mancini, G. B. J., Francis, G. A., & Brunham, L. R. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.065 · Cited by 76
Prevalence and Prognostic Significance of Asymptomatic Peripheral Arterial Disease in 68-year-old Men with Diabetes. Results from the Population Study ‘Men Born in 1914’ from Malmö, Sweden
Ögren, M., Hedblad, B., Engström, G., & Janzon, L. (2004) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2004.11.013 · Cited by 75
Intermittent nondaily dosing strategies in patients with previous statin-induced myopathy
Keating, A. J., Campbell, K. B., & Guyton, J. R. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r509 · Cited by 74
Association Between History of Adverse Pregnancy Outcomes and Coronary Artery Disease Assessed by Coronary Computed Tomography Angiography
Lawesson, S. S., Swahn, E., Pihlsgård, M., Andersson, T., Angerås, O., Brolin, E. B., Bergdahl, E., Blomberg, M. I., Christersson, C., Gonçalves, I., et al. (2023) · JAMA · doi:10.1001/jama.2022.24093 · Cited by 74
Global cardiovascular disease risk assessment in United States adults with diabetes
Wong, N. D., Glovaci, D., Wong, K., Malik, S., Franklin, S. S., Wygant, G. D., & Iloeje, U. H. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112436403 · Cited by 72
Risk Factors for Heart Failure in the Community: Differences by Age and Ejection Fraction
Chamberlain, A. M., Boyd, C. M., Manemann, S. M., Dunlay, S. M., Gerber, Y., Killian, J. M., Weston, S. A., & Roger, V. L. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.10.030 · Cited by 72
The interaction of familial and secondary causes of hypertriglyceridemia: role in pancreatitis
Brunzell, J. D., & Schrott, H. G. (2012) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2012.06.005 · Cited by 71
Prospective Association between Diabetic Retinopathy and Cardiovascular Disease—A Systematic Review and Meta-analysis of Cohort Studies
Guo, V. Y., Cao, B., Wu, X., Lee, J. J. W., & Zee, B. C.-Y. (2016) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2016.03.009 · Cited by 70
Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease
Nerlekar, N., Vasanthakumar, S. A., Whitmore, K., Soh, C. H., Chan, J., Goel, V., Ryan, J. D. M., Jones, C., Stanton, T., Mitchell, G. K., et al. (2025) · JAMA · doi:10.1001/jama.2025.0584 · Cited by 70
Statins and other lipid-lowering therapy and pregnancy outcomes in homozygous familial hypercholesterolaemia: A retrospective review of 39 pregnancies
Botha, T. C., Pilcher, G. J., Wolmarans, K., Blom, D. J., & Raal, F. J. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.05.038 · Cited by 70
Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: pooled analysis of alirocumab phase 3 trials
Ray, K. K., Vallejo-Vaz, A. J., Ginsberg, H. N., Davidson, M. H., Louie, M. J., Bujas-Bobanovic, M., Minini, P., Eckel, R. H., & Cannon, C. P. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.06.896 · Cited by 69
Modeling the Recommended Age for Initiating Coronary Artery Calcium Testing Among At-Risk Young Adults
Dzaye, O. D. A., Razavi, A. C., Dardari, Z., Shaw, L. J., Berman, D. S., Budoff, M. J., Miedema, M. D., Nasir, K., Rozanski, A., Rumberger, J. A., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.08.019 · Cited by 69
Self-citation
Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease
Hedegaard, B. S., Bork, C. S., Kaltoft, M., Klausen, I. C., Schmidt, E. B., Kamstrup, P. R., Langsted, A., & Nordestgaard, B. G. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.09.021 · Cited by 69
Evaluating Performance and Agreement of Coronary Heart Disease Polygenic Risk Scores
Abramowitz, S. A., Boulier, K. M., Keat, K., Cardone, K. M., Shivakumar, M., DePaolo, J. S., Judy, R., Bermudez, F., Mimouni, N., Neylan, C. J., et al. (2024) · JAMA · doi:10.1001/jama.2024.23784 · Cited by 69
Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients.
Wägner, A. M., Pérez, A., Calvo, F., Bonet, R., Castellví, A., & Ordóñez‐Llanos, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.812 · Cited by 69
Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1.5 Million Patients
Masana, L., Zamora, A., Plana, N., Comas‐Cufí, M., García-Gil, M., Martí‐Lluch, R., Ponjoan, A., Alves‐Cabratosa, L., Elosúa, R., Marrugat, J., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071080 · Cited by 68
Association of Carotid Artery Plaque With Cardiovascular Events and Incident Coronary Artery Calcium in Individuals With Absent Coronary Calcification
Mehta, A., Rigdon, J., Tattersall, M. C., German, C. A., Barringer, T. A., Joshi, P. H., Sperling, L. S., Budoff, M. J., Bertoni, A. G., Michos, E. D., et al. (2021) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.120.011701 · Cited by 68
Self-citation
Increasing Equity of Physical Activity Promotion for Optimal Cardiovascular Health in Adults: A Scientific Statement From the American Heart Association
Jerome, G. J., Boyer, W. R., Bustamante, E. E., Kariuki, J. K., López-Jiménez, F. A., Paluch, A. E., Swift, D. L., Webber‐Ritchey, K. J., & Gibbs, B. B. (2023) · Circulation · doi:10.1161/cir.0000000000001148 · Cited by 68
Association of Coronary Artery Calcium Detected by Routine Ungated CT Imaging with Cardiovascular Outcomes
Peng, A. W., Dudum, R., Jain, S. S., Maron, D. J., Patel, B. N., Khandwala, N., Eng, D., Chaudhari, A. S., Sandhu, A. T., & Rodriguez, F. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.06.040 · Cited by 67
Ezetimibe Treatment of Pediatric Patients with Hypercholesterolemia
Clauss, S. B., Wai, K., Kavey, R.-E. W., & KUEHL, K. S. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.12.044 · Cited by 66
Ketogenic diets, not for everyone
Goldberg, I. J., Ibrahim, N., Bredefeld, C., Foo, S. T., Lim, V., Gutman, D. C., Huggins, L.-A., & Hegele, R. A. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.10.005 · Cited by 66
Weight Loss in Short-Term Interventions for Physical Activity and Nutrition Among Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis
Rotunda, W., Rains, C. B., Jacobs, S., Ng, V., Lee, R., Rutledge, S., Jackson, M. C., & Myers, K. (2024) · Preventing Chronic Disease · doi:10.5888/pcd21.230347 · Cited by 66
Managing Incidental Findings on Thoracic CT: Lung Findings. A White Paper of the ACR Incidental Findings Committee
Munden, R. F., Black, W. C., Hartman, T. E., MacMahon, H., Ko, J. P., Dyer, D. S., Naidich, D. P., Rossi, S. E., McAdams, H. P., Goodman, E. M., et al. (2021) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2021.04.014 · Cited by 64
Diabetes Screening by Race and Ethnicity in the United States: Equivalent Body Mass Index and Age Thresholds
Aggarwal, R., Bibbins-Domingo, K. B., Yeh, R. W., Song, Y., Chiu, N., Wadhera, R. K., Shen, C., & Kazi, D. S. (2022) · Annals of Internal Medicine · doi:10.7326/m20-8079 · Cited by 64
The Effects of Different Degrees of Carbohydrate Restriction and Carbohydrate Replacement on Cardiometabolic Risk Markers in Humans—A Systematic Review and Meta-Analysis
Fechner, E., Smeets, E., Schrauwen, P., & Mensink, R. (2020) · Nutrients · doi:10.3390/nu12040991 · Cited by 64
Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes
Bhatt, D. L., Briggs, A. H., Reed, S. D., Annemans, L., Szarek, M. J., Bittner, V., Díaz, R., Goodman, S. G., Harrington, R. A., Higuchi, K., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.029 · Cited by 63
Self-citation
Moderate‐ and High‐Intensity Exercise Improves Lipoprotein Profile and Cholesterol Efflux Capacity in Healthy Young Men
Stanton, K., Kienzle, V., Dinnes, D. L. M., Kotchetkov, I., Jessup, W., Kritharides, L., Celermajer, D. S., & Rye, K. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023386 · Cited by 63
Efficacy of aerobic exercise and a prudent diet for improving selected lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials
Kelley, G. A., Kelley, K. S., Roberts, S. B., & Haskell, W. L. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-74 · Cited by 62
Subclinical Atherosclerosis: Part 1: What Is it? Can it Be Defined at the Histological Level?
Kawai, K., Finn, A. V., Virmani, R., Garg, P. K., Bhatia, H., Allen, T. W., Pouncey, A. L., Dichek, D. A., Golledge, J., Allison, M., et al. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319932 · Cited by 62
Inclisiran: a novel agent for lowering apolipoprotein B–containing lipoproteins
Warden, B. A., & Duell, P. B. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001053 · Cited by 62
Screening for Lipid Disorders in Children and Adolescents
Guirguis‐Blake, J., Evans, C. V., Coppola, E. L., Redmond, N., & Perdue, L. A. (2023) · JAMA · doi:10.1001/jama.2023.8867 · Cited by 61
Accuracy of 23 Equations for Estimating LDL Cholesterol in a Clinical Laboratory Database of 5,051,467 Patients
Samuel, C., Park, J.-S., Sajja, A. P., Michos, E. D., Blumenthal, R. S., Jones, S. R., & Martin, S. S. (2023) · Global Heart · doi:10.5334/gh.1214 · Cited by 59
Self-citation
Recall by genotype and cascade screening for familial hypercholesterolemia in a population-based biobank from Estonia
Alver, M., Palover, M., Saar, A., Läll, K., Zekavat, S. M., Tõnisson, N., Leitsalu, L., Reigo, A., Nikopensius, T., Ainla, T., et al. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0311-2 · Cited by 58
Self-citation
External Validation of the American Heart Association PREVENT Cardiovascular Disease Risk Equations
Scheuermann, B., Brown, A. R., Colburn, T. D., Hakeem, H., Chow, C. H., & Ade, C. J. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.38311 · Cited by 58
Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines
Sathiyakumar, V., Park, J., Quispe, R., Elshazly, M. B., Michos, E. D., Banach, M., Toth, P. P., Whelton, S. P., Blumenthal, R. S., Jones, S. R., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032463 · Cited by 58
Self-citation
Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry
Cuchel, M., Lee, P. C., Hudgins, L. C., Duell, P. B., Ahmad, Z., Baum, S. J., Linton, M. F., de Ferranti, S. D., Ballantyne, C. M., Larry, J. A., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.029175 · Cited by 58
Self-citation
Screening for Dysbetalipoproteinemia by Plasma Cholesterol and Apolipoprotein B Concentrations
Blom, D. J., O’Neill, F. H., & Marais, A. D. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.047001 · Cited by 57
Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses
Stürzebecher, P. E., Schorr, J., Klebs, S. H. G., & Laufs, U. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.01.014 · Cited by 57
Cardiovascular disease in familial hypercholesterolemia: Validation and refinement of the Montreal-FH-SCORE
Paquette, M., Brisson, D., Dufour, R., Khoury, É., Gaudet, D., & Baass, A. W. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.07.008 · Cited by 57
Association of statin use and clinical outcomes in heart failure patients: A systematic review and meta-analysis
Bielecka-Dabrowa, A., Bytyçi, I., Von Haehling, S., Anker, S., Jozwiak, J., Rysz, J., Hernandez, A. V., Bajraktari, G., Mikhalidis, D. P., & Banach, M. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1135-z · Cited by 57
Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association
Agarwala, A., Dixon, D. L., Gianos, E., Kirkpatrick, C. F., Michos, E. D., Satish, P., Birtcher, K. K., Braun, L. T., Pillai, P., Watson, K., et al. (2024) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2024.05.005 · Cited by 57
Self-citation
Effect of tirzepatide on blood pressure and lipids: a meta-analysis of randomized controlled trials
Kanbay, M., Copur, S., Siriopol, D., Yildiz, A. B., Gaipov, A., van Raalte, D. H., & Tuttle, K. R. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15272 · Cited by 56
Coronary calcification in SLE: comparison with the Multi-Ethnic Study of Atherosclerosis
Kiani, A. N., Magder, L. S., Post, W. S., Szklo, M., Bathon, J. M., Schreiner, P. J., O’Leary, D. H., & Petri, M. (2015) · Lara D. Veeken · doi:10.1093/rheumatology/kev198 · Cited by 56
Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies
Wald, D. S., & Bestwick, J. P. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.11.028 · Cited by 56
Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF
Feinstein, M. J., Jhund, P., Kang, J., Ning, H., Maggioni, A., Wikstrand, J., Kjekshus, J., Tavazzi, L., McMurray, J., & Lloyd-Jones, D. M. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.247 · Cited by 56
Self-citation
LDL-C calculated by Friedewald, Martin-Hopkins, or NIH equation 2 versus beta-quantification: pooled alirocumab trials
Ginsberg, H. N., Rosenson, R. S., Hovingh, G. K., Letierce, A., Samuel, R., Poulouin, Y., & Cannon, C. P. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100148 · Cited by 55
Self-citation
Coronary Artery Calcium Improves Risk Assessment in Adults With a Family History of Premature Coronary Heart Disease
Patel, J., Rifai, M. A., Blaha, M. J., Budoff, M. J., Post, W. S., Polak, J. F., Bluemke, D. A., Scheuner, M. T., Kronmal, R. A., Blumenthal, R. S., et al. (2015) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.003186 · Cited by 54
Self-citation
Reduction of Elevated LDL-Cholesterol Levels of 4- to 10-Year-Old Children Through Home-Based Dietary Education
Shannon, B. M., Martel, J. K., Achterberg, C., Smiciklas‐Wright, H., Tershakovec, A. M., Cortner, J. A., Stallings, V. A., & Stolley, P. D. (1994) · PEDIATRICS · doi:10.1542/peds.94.6.923 · Cited by 54
Cost-Effectiveness of Lipid-Lowering Treatments in Young Adults
Kohli-Lynch, C. N., Bellows, B. K., Zhang, Y., Spring, B. J., Kazi, D. S., Pletcher, M. J., Vittinghoff, E., Allen, N. B., & Moran, A. E. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.08.065 · Cited by 54
Novel Imaging Approaches to Cardiac Manifestations of Systemic Inflammatory Diseases
Weber, B., Paik, J. J., Aghayev, A., Klein, A. L., Mavrogeni, S. I., Yu, P. B., & Mukherjee, M. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.09.819 · Cited by 54
Basic vs More Complex Definitions of Family History in the Prediction of Coronary Heart Disease: The Multi-Ethnic Study of Atherosclerosis
Patel, J., Rifai, M. A., Scheuner, M. T., Shea, S., Blumenthal, R. S., Nasir, K., Blaha, M. J., & McEvoy, J. W. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.01.014 · Cited by 53
Self-citation
SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia
Gallo, A., Charrière, S., Vimont, A., Chapman, M. J., Angoulvant, D., Boccara, F., Cariou, B., Carreau, V., Carrié, A., Bruckert, É., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.06.011 · Cited by 53
Socioeconomic status and dyslipidemia in Korean adults: The 2008–2010 Korea National Health and Nutrition Examination Survey
Nam, G. E., Cho, K.-H., Park, Y. G., Han, K., Choi, Y. S., Kim, S. M., Lee, K. S., Ko, B. J., Kim, Y., Han, B. D., et al. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2013.06.008 · Cited by 52
Self-citation
Excess Risk for Atherosclerotic Cardiovascular Outcomes Among US Adults With HIV in the Current Era
Rosenson, R. S., Hubbard, D. M., Monda, K. L., Reading, S. R., Chen, L., Dluzniewski, P. J., Burkholder, G., Muntner, P., & Colantonio, L. D. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013744 · Cited by 52
Self-citation
Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the US
Madhav, K. C., Fan, J., Hyslop, T., Hassan, S., Cecchini, M., Wang, S., Silber, A. L. M., Leapman, M., Leeds, I. L., Wheeler, S. B., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.23115 · Cited by 52
Delivery of a Small-For-Gestational-Age Infant and Risk of Maternal Cardiovascular Disease – A Population-Based Record Linkage Study
Ngo, A. D., Roberts, C. L., Chen, J. S., & Figtree, G. A. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2015.01.004 · Cited by 51
The risk of cardiovascular diseases after miscarriage, stillbirth, and induced abortion: a systematic review and meta-analysis
Kyriacou, H., Al-Mohammad, A., Muehlschlegel, C., Foster-Davies, L., Bruco, M. E. F., Legard, C., Fisher, G., Simmons-Jones, F., & Oliver‐Williams, C. (2022) · European Heart Journal Open · doi:10.1093/ehjopen/oeac065 · Cited by 51
Screening for Dyslipidemia in Younger Adults: A Systematic Review for the U.S. Preventive Services Task Force
Chou, R., Dana, T., Blazina, I., Daeges, M., Bougatsos, C., & Jeanne, T. L. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0946 · Cited by 51
Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion
Ogura, M., Makino, H., Kamiya, C., Yoshimatsu, J., Soran, H., Eatough, R., Perrone, G., Harada‐Shiba, M., & Stefanutti, C. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.018 · Cited by 51
Effectiveness of dietetic consultation for lowering blood lipid levels in the management of cardiovascular disease risk: A systematic review and meta‐analysis of randomised controlled trials
ROSS, L. J., Barnes, K. A., Ball, L., Mitchell, L. J., Sladdin, I., Lee, P. J., & Williams, L. T. (2019) · Nutrition & Dietetics · doi:10.1111/1747-0080.12509 · Cited by 50
The Role of Sex-Specific Risk Factors in the Risk Assessment of Atherosclerotic Cardiovascular Disease for Primary Prevention in Women
Freaney, P. M., Khan, S. S., Lloyd‐Jones, D. M., & Stone, N. J. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00864-6 · Cited by 50
Self-citation
Prevention of atherosclerotic cardiovascular disease in South Asians in the US: A clinical perspective from the National Lipid Association
Kalra, D. K., Vijayaraghavan, K., Sikand, G., Desai, N. R., Joshi, P. H., Mehta, A., Karmally, W., Vani, A. K., Sitafalwalla, S. J., Puri, R., et al. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.03.007 · Cited by 50
Self-citation
Effects of Pitavastatin in Japanese Patients With Chronic Heart Failure
Takano, H., Mizuma, H., Kuwabara, Y., Sato, Y., Shindo, S., Kotooka, N., Fujimatsu, D., Kobayashi, Y., Inoue, T., Node, K., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-1062 · Cited by 50
Targeting cholesterol homeostasis in hematopoietic malignancies
Brendolan, A., & Russo, V. E. A. (2021) · Blood · doi:10.1182/blood.2021012788 · Cited by 50
Coronary artery calcium scores indicating secondary prevention level risk: Findings from the CAC consortium and FOURIER trial
Dzaye, O. D. A., Razavi, A. C., Michos, E. D., Mortensen, M. B., Dardari, Z., Nasir, K., Osei, A. D., Peng, A. W., Blankstein, R., Page, J. H., et al. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.02.006 · Cited by 50
Self-citation
Heterogeneity in cardio-metabolic risk factors and atherosclerotic cardiovascular disease among Asian groups in the United States
Satish, P., Sadaf, M. I., Valero-Elizondo, J., Grandhi, G. R., Yahya, T., Zawahir, H., Javed, Z., Mszar, R., Hanif, B., Kalra, A., et al. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100219 · Cited by 48
Self-citation
Coronary Artery Calcification and Plaque Characteristics in People Living With HIV: A Systematic Review and Meta‐Analysis
Soares, C., Samara, A., Yuyun, M. F., Echouffo-Tcheugui, J. B., Masri, A., Samara, A., Morrison, A., Lin, N., Wu, W., & Erqou, S. A. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019291 · Cited by 47
Statin Use in Pregnancy: Is It Time For a Paradigm Shift?
Mauricio, R., & Khera, A. (2022) · Circulation · doi:10.1161/circulationaha.121.058983 · Cited by 47
INOVASIA Study: A Multicenter Randomized Clinical Trial of Pravastatin to Prevent Preeclampsia in High-Risk Patients
Akbar, M. I. A., Azis, M. A., Riu, D. S., Wawengkang, E., Ernawati, E., Bachnas, M. A., Sulistyowati, S., Dachlan, E. G., Mose, J. C., & Dekker, G. (2022) · American Journal of Perinatology · doi:10.1055/a-1798-1925 · Cited by 47
Development and validation of an isoform-independent monoclonal antibody–based ELISA for measurement of lipoprotein(a)
Marcovina, S. M., Navabi, N., Allen, S., Gonen, A., Witztum, J. L., & Tsimikas, S. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100239 · Cited by 47
Advances in Coronary Computed Tomographic Angiographic Imaging of Atherosclerosis for Risk Stratification and Preventive Care.
Bienstock, S. W., Lin, F., Blankstein, R., Leipsic, J., Cardoso, R., Ahmadi, A., Gelijns, A., Patel, K. K., Baldassarre, L., Hadley, M. B., et al. (2023) · JACC Cardiovascular Imaging · doi:10.1016/j.jcmg.2023.02.002 · Cited by 47
Self-citation
Association of high maternal triglyceride levels early and late in pregnancy with adverse outcomes: A retrospective cohort study
Xue, R., Wu, D., Zhou, C., Chen, L., Li, J., Li, Z.-Z., Fan, J., Liu, X.-M., Lin, X.-H., & Huang, H. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.10.001 · Cited by 47
Pregnancy in a patient with homozygous familial hypercholesterolemia treated with long-term low-density lipoprotein apheresis
Kroon, A. A., Swinkels, D. W., van Dongen, P. W. J., & Stalenhoef, A. F. H. (1994) · Metabolism · doi:10.1016/0026-0495(94)90061-2 · Cited by 45
Hypertriglyceridemia-induced pancreatitis created by oral estrogen and in vitro fertilization ovulation induction
Lee, J., & Goldberg, I. J. (2007) · Journal of clinical lipidology · doi:10.1016/j.jacl.2007.11.001 · Cited by 45
Statins Decrease Programmed Death-Ligand 1 (PD-L1) by Inhibiting AKT and β-Catenin Signaling
Lim, W.-J., Lee, M., Oh, Y., Fang, X.-Q., Lee, S., Lim, C.-H., Park, J., & Lim, J.-H. (2021) · Cells · doi:10.3390/cells10092488 · Cited by 45
Unique features of dyslipidemia in women across a lifetime and a tailored approach to management
Patel, N., Mittal, N., Wilkinson, M. J., & Taub, P. R. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100666 · Cited by 45
Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial
Goodman, S. G., Steg, P. G., Poulouin, Y., Bhatt, D. L., Bittner, V. A., Diaz, R., Garon, G., Harrington, R. A., Jukema, J. W., Manvelian, G., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.029216 · Cited by 44
Self-citation
Work, sleep, and cholesterol levels of U.S. long-haul truck drivers
Lemke, M. K., Apostolopoulos, Y., Hege, A., Wideman, L., & Sönmez, S. (2016) · Industrial Health · doi:10.2486/indhealth.2016-0127 · Cited by 44
Safety of ezetimibe in lipid-lowering treatment: systematic review and meta-analysis of randomised controlled trials and cohort studies
Wang, Y., Zhan, S., Du, H., Li, J., Khan, S. U., Aertgeerts, B., Guyatt, G. H., Hao, Q., Bekkering, G. E., Li, L., et al. (2022) · BMJ Medicine · doi:10.1136/bmjmed-2022-000134 · Cited by 44
What to say and how to say it
Návar, A. M., Stone, N. J., & Martin, S. S. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000322 · Cited by 43
Self-citation
Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy
Návar, A. M., Wang, T. Y., Li, S., Mi, X., Li, Z., Robinson, J. G., Virani, S. S., & Peterson, E. D. (2021) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.120.006548 · Cited by 43
Self-citation
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Preventive Cardiology
Virani, S. S., Aspry, K. E., Dixon, D. L., Ferdinand, K. C., Heidenreich, P. A., Jackson, E. J., Jacobson, T. A., McAlister, J. L., Neff, D., Gulati, M., et al. (2023) · Journal of clinical lipidology · doi:10.1016/j.jacl.2023.02.003 · Cited by 43
Self-citation
Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific Optimization
Smith, J. L., Tcheandjieu, C., Dikilitas, O., Iyer, K. R., Miyazawa, K., Hilliard, A. T., Lynch, J. A., Rotter, J. I., Chen, Y.-D. I., Sheu, W. H., et al. (2024) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.123.004272 · Cited by 43
Impact of Patient Visualization of Cardiovascular Images on Modification of Cardiovascular Risk Factors
Whitmore, K., Zhou, Z., Chapman, N., Huynh, Q. L., Magnussen, C. G., Sharman, J. E., & Marwick, T. H. (2023) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2023.03.007 · Cited by 43
Cardiovascular Outcomes Associated with Lowering Low-density Lipoprotein Cholesterol in Rheumatoid Arthritis and Matched Nonrheumatoid Arthritis
An, J., Alemao, E., Reynolds, K., Kawabata, H., Solomon, D. H., Liao, K. P., Niu, F., & Cheetham, T. C. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.160110 · Cited by 42
Pregnancy outcomes following maternal exposure to statins: A systematic review and meta‐analysis
Karadaş, B., Uysal, N., Erol, H., Acar, S., Koç, M., Temiz, T. K., Koren, G., & Kaplan, Y. C. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15423 · Cited by 42
Association of Autoimmune Diseases With Coronary Atherosclerosis Severity and Ischemic Events
Mortensen, M. B., Jensen, J. M., Sand, N. P. R., Kragholm, K. H., Blaha, M. J., Grove, E. L., Sørensen, H. T., Olesen, K. K. W., Mæng, M., Løgstrup, B. B., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.04.030 · Cited by 42
Asymptomatic Individuals With a Positive Family History for Premature Coronary Artery Disease and Elevated Coronary Calcium Scores Benefit From Statin Treatment
Mulders, T. A., Sivapalaratnam, S., Stroes, E. S. G., Kastelein, J. J. P., Guerci, A. D., & Pinto‐Sietsma, S. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.11.014 · Cited by 42
Hypertriglyceridemic acute pancreatitis during pregnancy: Prevention with diet therapy and ω-3 fatty acids in the following pregnancy
Takaishi, K., Miyoshi, J., Matsumura, T., Honda, R., Ohba, T., & Katabuchi, H. (2009) · Nutrition · doi:10.1016/j.nut.2009.04.009 · Cited by 42
Evaluation of a multidisciplinary lipid clinic to improve the care of individuals with severe lipid conditions: a RE-AIM framework analysis
Jones, L. K., McMinn, M., Kann, D., Lesko, M. G., Sturm, A. C., Walters, N., Chen, N., Fry, K., Brownson, R. C., Gidding, S. S., et al. (2021) · Implementation Science Communications · doi:10.1186/s43058-021-00135-8 · Cited by 41
Ancestry-specific polygenic risk scores are risk enhancers for clinical cardiovascular disease assessments
Busby, G., Kulm, S., Bolli, A., Kintzle, J., Domenico, P. D., & Bottà, G. (2023) · Nature Communications · doi:10.1038/s41467-023-42897-w · Cited by 41
AHA PREVENT Equations and Lipoprotein(a) for Cardiovascular Disease Risk
Bhatia, H. S., Ambrosio, M., Razavi, A. C., Alebna, P. L., Yeang, C., Spitz, J. A., Patel, J., Tsai, M. Y., Sperling, L. S., Shapiro, M. D., et al. (2025) · JAMA Cardiology · doi:10.1001/jamacardio.2025.1603 · Cited by 41
Self-citation
Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System
Jia, X., Al Rifai, M., Ramsey, D. J., Ahmed, S. T., Akeroyd, J. M., Nambi, V., Ballantyne, C. M., Petersen, L. A., Stone, N. J., & Virani, S. S. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.04.002 · Cited by 41
Self-citation
Adherence with lipid screening guidelines in standard- and high-risk children and adolescents
Berger, J. H., Chen, F., Faerber, J., O'Byrne, M. L., & Brothers, J. A. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.10.058 · Cited by 40
Low-Dose Pravastatin and Age-Related Differences in Risk Factors for Cardiovascular Disease in Hypercholesterolaemic Japanese
Nakaya, N., Mizuno, K., Ohashi, Y., Teramoto, T., Yokoyama, S., Hirahara, K., Mizutani, M., & Nakamura, H. (2011) · Drugs & Aging · doi:10.2165/11595620-000000000-00000 · Cited by 39
Cost-effectiveness and Return on Investment of a Nationwide Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands.
Ademi, Z., Norman, R., Pang, J., Sijbrands, E., Watts, G., Hutten, B., & Wiegman, A. (2023) · JAMA pediatrics · doi:10.1001/jamapediatrics.2023.0763 · Cited by 39

Research works printed but not linked: 243

Kazi DS, Abdullah AR, Arnold SV, et al. 2025 AHA/ACC statement on cost/value methodology in clinical practice guidelines (update from 2014 statement): a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;151:e332–e358.
Otto CM, Abdullah AR, Davis LL, et al. 2025 ACC/AHA guideline core principles and development process: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;152:e359–e370.
Jneid H, Abdullah AR, Ferrari V, et al. Guidance for incorporating FDA processes into the ACC/AHA clinical practice guideline methodology: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;152:e323–e331.
Vuorio A, Kuoppala J, Kovanen PT, et al. Statins for children with familial hypercholesterolemia. Cochrane Database Syst Rev. 2019;2019(11):CD006401.
Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128 Suppl 5:S213–S256.
Centers for Disease Control and Prevention (CDC). Prevalence of abnormal lipid levels among youths-United States, 1999-2006. MMWR Morb Mortal Wkly Rep. 2010;59:29–33.
10.1016/S0140-6736(19)32519-X · DOI
10.1161/CIR.0000000000000625 · DOI · Paper page
10.1161/CIRCULATIONAHA.119.041149 · DOI · Paper page
MacDougall DE, Tybjaerg-Hansen A, Knowles JW, et al. Lipoprotein(a) and recurrent atherosclerotic cardiovascular events: the US Family Heart Database. Eur Heart J. 2025;ehaf297.
10.1056/NEJMoa1812792 · DOI · Paper page
10.1056/NEJMoa1615664 · DOI · Paper page
10.1056/NEJMoa2215024 · DOI · Paper page
10.1161/CIR.0000000000001078 · DOI · Paper page
10.1161/CIR.0000000000000678 · DOI · Paper page
10.1056/NEJMoa2109191 · DOI
10.1056/NEJMoa1800389 · DOI · Paper page
10.1161/CIR.0000000000000678 · DOI · Paper page
10.1161/CIR.0000000000000625 · DOI · Paper page
10.1016/j.jacc.2021.06.011 · DOI · Paper page
10.1210/clinem/dgaa673 · DOI · Paper page
10.1093/eurheartj/ehad211 · DOI
10.1161/CIR.0000000000000678 · DOI · Paper page
10.1111/j.1467-789X.2012.01021.x · DOI · Paper page
10.1016/j.jacl.2023.05.099 · DOI
10.1093/ajcn/56.2.320 · DOI · Paper page
10.1161/CIR.0000000000001078 · DOI · Paper page
10.1007/s40279-024-02115-z · DOI · Paper page
10.1056/NEJMoa020194 · DOI · Paper page
Li Y, Zhai Q, Li G, et al. Effects of different aerobic exercises on blood lipid levels in middle-aged and elderly people: a systematic review and bayesian network meta-analysis based on randomized controlled trials. Healthcare (Basel). 2024;12:1309.
10.1161/CIR.0b013e3182160726 · DOI · Paper page
US Department of Health and Human Services. Physical Activity Guidelines for Americans. 2nd edition. US Department of Health and Human Services; 2018.
10.1056/NEJMoa1410489 · DOI · Paper page
10.1056/NEJMoa1615664 · DOI · Paper page
10.1016/j.jacc.2021.06.011 · DOI · Paper page
10.1016/j.jacc.2021.06.011 · DOI · Paper page
10.1016/j.jacl.2023.05.099 · DOI
10.1016/j.jacc.2021.06.011 · DOI · Paper page
10.1056/NEJMoa1812792 · DOI · Paper page
10.1016/j.jacc.2022.07.006 · DOI · Paper page
10.1161/CIR.0000000000000709 · DOI · Paper page
10.1161/CIR.0000000000000625 · DOI · Paper page
10.1161/CIR.0000000000000456 · DOI
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–1389.
10.1016/S0140-6736(10)61350-5 · DOI · Paper page
10.1016/j.jacc.2022.07.006 · DOI · Paper page
10.1056/NEJMoa1410489 · DOI · Paper page
10.1056/NEJMoa1615664 · DOI · Paper page
10.1056/NEJMoa1801174 · DOI · Paper page
10.1016/j.atherosclerosis.2018.06.002 · DOI · Paper page
10.1161/JAHA.118.011662 · DOI · Paper page
10.1016/j.jacc.2021.06.011 · DOI · Paper page
10.1016/j.jacc.2020.07.059 · DOI · Paper page
10.1161/circulationaha.114.012477 · DOI
Zheutlin AR, Handoo F, Luebbe S, et al. Cumulative exposure to atherogenic lipoprotein particles in young adults and subsequent incident atherosclerotic cardiovascular disease. Eur Heart J. 2025;eha472.
10.1056/NEJMoa2109191 · DOI
10.1001/jamacardio.2021.3508 · DOI · Paper page
Stacey D, Legare F, Lewis K, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;4:CD001431.
10.1161/CIR.0000000000000625 · DOI · Paper page
10.1161/CIRCULATIONAHA.123.067626 · DOI · Paper page
10.1016/S0140-6736(12)60367-5 · DOI · Paper page
10.1161/01.cir.0000437738.63853.7a · DOI · Paper page
10.1161/CIR.0000000000000625 · DOI · Paper page
10.1161/CIR.0000000000000678 · DOI · Paper page
10.1161/ATVBAHA.120.315291 · DOI · Paper page
10.1056/NEJMoa0807646 · DOI · Paper page
10.1056/NEJMoa1107477 · DOI · Paper page
10.1161/CIR.0000000000000625 · DOI · Paper page
10.1161/CIR.0000000000000678 · DOI · Paper page
Urbut SM, Cho SMJ, Paruchuri K, et al. Dynamic importance of genomic and clinical risk for coronary artery disease over the life course. Circ Genom Precis Med. 2023;18:e004681.
10.1001/jama.2025.0584 · DOI
10.1093/eurheartj/ehad211 · DOI
10.1007/s40279-024-02115-z · DOI · Paper page
10.1210/clinem/dgaa673 · DOI · Paper page
10.1016/S0140-6736(12)60367-5 · DOI · Paper page
10.1016/j.jacc.2020.07.059 · DOI · Paper page
10.1056/NEJMoa0807646 · DOI · Paper page
10.1056/NEJMoa1600176 · DOI · Paper page
10.1001/jama.279.20.1615 · DOI · Paper page
10.1001/jamacardio.2021.3508 · DOI · Paper page
10.1001/jama.2016.13985 · DOI · Paper page
10.1056/NEJMoa2215024 · DOI · Paper page
10.1161/CIR.0000000000000678 · DOI · Paper page
10.1161/circulationaha.114.012477 · DOI
10.1161/01.cir.0000437738.63853.7a · DOI · Paper page
10.1161/CIR.0000000000000625 · DOI · Paper page
10.7326/M16-0946 · DOI
10.1016/S0140-6736(10)61350-5 · DOI · Paper page
10.1161/CIRCULATIONAHA.123.064168 · DOI
10.1161/circulationaha.116.022335 · DOI
10.1016/j.jacc.2016.03.520 · DOI · Paper page
10.1161/CIRCULATIONAHA.123.064168 · DOI
10.1056/NEJM199511163332001 · DOI · Paper page
10.1016/j.jacc.2016.03.520 · DOI · Paper page
10.1161/CIRCULATIONAHA.116.024541 · DOI
10.1056/NEJMoa1410489 · DOI · Paper page
10.1056/NEJMoa2215024 · DOI · Paper page
Kastelein JJ, Ginsberg HN, Langslet G, et al. ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia. Eur Heart J. 2015;36:2996–3003.
Raal F, Durst R, Bi R, et al. Efficacy, safety, and tolerability of inclisiran in patients with homozygous familial hypercholesterolemia: results from the ORION-5 randomized clinical trial. Circulation. 2023;354–362.
10.1001/jama.2016.13985 · DOI · Paper page
10.1016/S0140-6736(10)61350-5 · DOI · Paper page
10.1016/j.jacc.2021.06.011 · DOI · Paper page
10.1016/S0140-6736(14)61374-X · DOI
10.1056/NEJMoa2215024 · DOI · Paper page
10.1001/jama.2016.13985 · DOI · Paper page
10.1056/NEJM199511163332001 · DOI · Paper page
10.1161/CIRCULATIONAHA.117.027966 · DOI · Paper page
10.1136/bmj.a2423 · DOI
10.1016/j.jacc.2016.04.054 · DOI
10.1016/S0140-6736(10)61350-5 · DOI · Paper page
10.1161/CIRCULATIONAHA.122.063460 · DOI · Paper page
10.1056/NEJMoa1410489 · DOI · Paper page
10.1056/NEJMoa1812792 · DOI · Paper page
10.1001/jama.2016.13985 · DOI · Paper page
10.1056/NEJMoa0807646 · DOI · Paper page
10.1016/S0140-6736(10)61350-5 · DOI · Paper page
10.1056/NEJMoa2215024 · DOI · Paper page
10.1001/jama.2023.9696 · DOI · Paper page
10.1056/NEJMoa1615664 · DOI · Paper page
10.1056/NEJMoa1801174 · DOI · Paper page
10.1161/CIR.0000000000000625 · DOI · Paper page
10.1016/S0140-6736(10)61350-5 · DOI · Paper page
10.1001/jama.2016.13985 · DOI · Paper page
10.1056/NEJMoa1410489 · DOI · Paper page
10.1056/NEJMoa2215024 · DOI · Paper page
10.1056/NEJMoa1801174 · DOI · Paper page
10.1056/NEJMoa1615664 · DOI · Paper page
10.1161/CIRCULATIONAHA.122.061620 · DOI · Paper page
10.1161/CIR.0000000000000625 · DOI · Paper page
10.1161/JAHA.122.029216 · DOI · Paper page
10.1016/j.jacc.2020.07.059 · DOI · Paper page
10.1056/NEJMoa1801174 · DOI · Paper page
10.1177/2047487319864671 · DOI · Paper page
10.1016/j.jcmg.2019.02.005 · DOI · Paper page
10.1016/j.jcmg.2023.03.008 · DOI
10.1093/eurheartj/ehy217 · DOI · Paper page
10.1001/jama.2025.0584 · DOI
10.1016/j.jacc.2018.09.051 · DOI
10.1001/jamacardio.2016.5493 · DOI
10.1016/j.jcct.2023.10.001 · DOI
10.1148/radiol.15142062 · DOI · Paper page
10.1161/CIRCULATIONAHA.122.062746 · DOI · Paper page
10.1016/j.jacl.2020.12.005 · DOI
10.1056/NEJMoa2215024 · DOI · Paper page
Cannon CP, Blazing MA, Braunwald E. Ezetimibe plus a statin after acute coronary syndromes. N Engl J Med. 2015;373:1476–1477.
10.1056/NEJMoa1615664 · DOI · Paper page
10.1056/NEJMoa1801174 · DOI · Paper page
10.1161/circulationaha.116.027034 · DOI
10.1016/S0140-6736(10)61350-5 · DOI · Paper page
10.1161/CIRCIMAGING.120.011701 · DOI
10.1001/jamacardio.2024.5702 · DOI
10.1093/ehjci/jex239 · DOI · Paper page
Vuorio A, Kuoppala J, Kovanen PT, et al. Statins for children with familial hypercholesterolemia. Cochrane Database Syst Rev. 2019;2019(11):CD006401.
10.1056/NEJMoa1816454 · DOI
10.1126/science.aaf7000 · DOI · Paper page
Schmieder RS, Krefting J, Ates S, et al. Clinical scores fail to sufficiently identify children with familial hypercholesterolemia. Eur J Prev Cardiol. 2025;zwaf301.
10.1001/jama.2019.4984 · DOI
10.1001/jamapediatrics.2021.2046 · DOI
10.1161/CIRCULATIONAHA.119.044795 · DOI
10.1016/j.jacc.2015.02.020 · DOI · Paper page
10.1056/NEJMoa2109191 · DOI
10.1001/jama.2023.8867 · DOI
10.1056/NEJMoa1602777 · DOI
10.1161/CIR.0000000000000625 · DOI · Paper page
10.1161/circulationaha.114.012477 · DOI
10.1016/j.jacc.2020.07.059 · DOI · Paper page
10.1056/NEJMoa2109191 · DOI
10.1161/circulationaha.116.022335 · DOI
10.1001/jamacardio.2021.3508 · DOI · Paper page
10.1001/jamanetworkopen.2021.36802 · DOI
10.1001/jamainternmed.2015.0289 · DOI · Paper page
10.1016/j.jacc.2016.05.084 · DOI
10.1161/CIR.0000000000001191 · DOI · Paper page
Martin SS, Aday AW, Allen NB, et al. 2025 Heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2025;25:e41–e660.
10.1161/CIR.0000000000000625 · DOI · Paper page
10.1161/CIR.0000000000000678 · DOI · Paper page
Dudum R, Huang Q, Yan XS, et al. Lipoprotein(a) levels in disaggregated racial and ethnic subgroups across atherosclerotic cardiovascular disease risk levels. J am Coll Cardiol Adv. 2024;3:100940.
10.1056/NEJMoa0706201 · DOI · Paper page
10.1016/S0140-6736(08)61240-4 · DOI · Paper page
10.1161/CIR.0000000000000625 · DOI · Paper page
10.1002/ejhf.247 · DOI · Paper page
10.1016/S0140-6736(11)60739-3 · DOI · Paper page
Tunnicliffe DJ, Palmer SC, Cashmore BA, et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev. 2023;2023:.
Igweonu-Nwakile EO, Ali S, Paul S, et al. A systematic review on the safety and efficacy of PCSK9 inhibitors in lowering cardiovascular risks in patients with chronic kidney disease. Cureus. 2022;14:e29140.
10.1016/j.jacc.2022.07.006 · DOI · Paper page
10.1001/jamainternmed.2013.3728 · DOI
10.1161/CIR.0000000000000456 · DOI
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services. Accessed August 24 2025. https://www.ncbi.nlm.nih.gov/sites/books/NBK586306/.
Sarkar S, Brown TT. Lipid disorders in people with HIV. Table 5. Interaction of antiretroviral therapy and statins. In: Feingold KR, Ahmed SF, Anawalt B, et al, editors. Endotext. MDText.com, Inc.; 2000. Accessed November 21, 2025. https://www.ncbi.nlm.nih.gov/books/NBK567198/table/lipid_hiv.T.interaction_of_antiretrovira.
10.1001/jamainternmed.2020.6084 · DOI · Paper page
10.1001/jamainternmed.2015.0289 · DOI · Paper page
10.1093/ajcn/56.2.320 · DOI · Paper page
10.1210/clinem/dgaa673 · DOI · Paper page
10.1056/NEJMoa1615664 · DOI · Paper page
10.1056/NEJMoa1801174 · DOI · Paper page
10.1056/NEJMoa2215024 · DOI · Paper page
10.1056/NEJMoa1812792 · DOI · Paper page
10.1161/CIRCULATIONAHA.123.067626 · DOI · Paper page
10.1016/j.jacc.2021.06.011 · DOI · Paper page
10.1016/j.jacl.2024.08.013 · DOI · Paper page

200 of 243 shown

Sorted by citations

2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Ndumele, C. E., Rodríguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M. S., Bangalore, S., Bozkurt, B., Breathett, K. K., Clarke, S. L., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001453 · Cited by 101
Self-citation
Epidemiology of cardiovascular–kidney–metabolic syndrome
Mavromatis, L. A., & Grams, M. E. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-026-01078-w · Cited by 12
Global Burden of Elevated LDL-C
Collaborators, G. 2. L. C., Razo, C., DeCleene, N. K., Johnson, C. O., Stark, B. A., LeGrand, K. E., Aalruz, H., Abaraogu, U. O., ElHafeez, S. A., Abdelmasseh, M., et al. (2026) · JAMA · doi:10.1001/jama.2026.8628 · Cited by 8
Lipoprotein(a) Levels, Risk of Cardiovascular Events, and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial
Monguillon, V., Marston, N., Bohula, E. A., Park, J., Kuder, J., Murphy, S. A., Ferrari, G. M. D., Leiter, L. A., Nicolau, J. C., Ebenbichler, C. F., et al. (2026) · Circulation · doi:10.1161/circulationaha.126.080999 · Cited by 7
Self-citation
Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology
Khan, S. S., Bhave, N. M., Blumenthal, R. S., Coresh, J., Huang, X., Joseph, J. J., Khera, A., Ho, J. E., Lloyd‐Jones, D. M., Wang, C. C. L., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001447 · Cited by 11
Self-citation

See all 122

Authors: Writing Committee Members, Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., de Ferranti, S. D., Gianos, E., Gluckman, T. J., Gradney, K. F., Isiadinso, I., Lloyd-Jones, D. M., Marrs, J. C., Martin, S. S., McLain, K. H., Mehta, L. S., Mora, S., Mulugeta, W. M., Natarajan, P., Navar, A. M., Orringer, C. E., Polonsky, T. S., Reynolds, H. R., Saseen, J. J., Shapiro, M. D., Soffer, D. E., Tynes, S. A., Villavaso, C. D., Virani, S. S., Wilkins, J. T., Rohatgi, A., Kim, S. M., Alexander, K. P., Anderson, C., Benziger, C. P., Dixon, D. L., Duprez, D., Ferdinand, K. C., Goldberg, A. C., Joshi, P., Knowles, J. W., Lavie Jr, C. (. J., Linderbaum, J. A., McEvoy, J. W., Mehta, A., Merz, C. N. B., Nambi, V., Orkaby, A. R., Peña, Rosenson, R., Ruisinger, J., Sandner, S. E., Schott, S. L., Sperling, L. (., Stone, N. J., Toth, P., Ware, A. L., Whelton, S. P., & Young, J.
Affiliations: American Hospital Association (US)
Former ACC/AHA Joint Committee on Clinical Practice Guidelines member; current member during the writing effort.
American Geriatrics Society (US)
American Association of Cardiovascular and Pulmonary Rehabilitation representative.
ACC/AHA Task Force on Performance Measures liaison.
Patient representative.
Association of Black Cardiologists (US)
American Pharmacists Association (US)
American College of Preventive Medicine (US)
National Lipid Association (US)
American Society for Preventive Cardiology representative.
AHA/ACC Guidelines Staff Consultant.
Preventive Cardiovascular Nurses Association representative.
American Diabetes Association (US)
ORCID: Blumenthal, Roger S.
Gaudino, Mario
Johnson, Heather M.
Anderson, Timothy S.
Bittner, Vera A.
Blankstein, Ron
Brewer, LaPrincess C.
Cho, Leslie
de Ferranti, Sarah D.
Gianos, Eugenia
Gluckman, Ty J.
Isiadinso, Ijeoma
Marrs, Joel C.
Mehta, Laxmi S.
Mora, Samia
Mulugeta, Wudeneh M.
Natarajan, Pradeep
Orringer, Carl E.
Polonsky, Tamar S.
Reynolds, Harmony R.
Saseen, Joseph J.
Soffer, Daniel E.
Wilkins, John T.
Rohatgi, Anand
Alexander, Karen P.
Benziger, Catherine P.
Dixon, Dave L.
Ferdinand, Keith C.
Goldberg, Anne Carol
Knowles, Joshua W.
Linderbaum, Jane A.
McEvoy, John William
Nambi, Vijay
Orkaby, Ariela R.
Peña,, Jessica M.
Rosenson, Robert
Ruisinger, Janelle
Sandner, Sigrid E.
Schott, Stacey L.
Stone, Neil J.
Toth, Peter
Ware, Adam L.
Whelton, Seamus Paul
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2026-04-28
Volume: 153
Issue: 17
Pages: e1154-e1276
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/cir.0000000000001423
OpenAlex: W7135196205
Cited by: 122
References: 752
Citations by year: 2026: 122
FWCI: 769.87
Type: journal article
Language: en
Update notices: correction (2026-06-22)
correction (2026-09-08)
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Keywords: dyslipidemia, dyslipidemia management, hypercholesterolemia, hypertriglyceridemia, serum cholesterol, lipid-lowering therapy, cardiovascular risk, lipid monitoring
MeSH terms: American Heart Association, Hypolipidemic Agents, Cardiology, Humans, United States, Dyslipidemias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks